Iceland· IS-EU/1/20/1439/001-004 & 013
Atectura Breezhaler
A indacaterol und mometason product containing indacaterolum inn acetat,mometasonum inn fúróat, registered in Iceland by Novartis Europharm Limited*. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Indacaterol und mometason is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AK14 (indacaterol und mometason), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Indacaterol und mometason · ATC R03AK14
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of indacaterol und mometason costs, country by country.
Normalised to the WHO defined daily dose (0.15 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Indacaterol und mometason · price per daily dose (0.15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.85
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Indacaterolum INN acetat,Mometasonum INN fúróat
- Manufacturer
- Novartis Europharm Limited*
- Country
- Iceland (IS)
- ATC code
- R03AK14
- ATC class
- Indacaterol und Mometason
- Defined daily dose
- 0.15 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indacaterol und mometason in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaATECTURA BREEZHALERNovartis Europharm Limited, Dublin
- SpainATECTURA BREEZHALER 125 microgramos/127,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)Novartis Europharm Limited
- FinlandAtectura BreezhalerNovartis Europharm Limited
- PolandAtectura BreezhalerNovartis Europharm Limited
- SwedenAtectura Breezhaler 125 mikrogram/127,5 mikrogram Inhalationspulver, hård kapselNovartis Europharm Limited
- SwitzerlandAtectura Breezhaler
- IrelandAtectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsulesNovartis Europharm Limited
- United KingdomAtectura Breezhaler 125micrograms/127.5micrograms inhalation powder capsules with deviceNovartis Pharmaceuticals UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Atectura Breezhaler, Bemrist Breezhaler
- Norway · Atectura Breezhaler, Bemrist Breezhaler
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5cdeaf00-6ddf-4194-8eb9-c4c0b6050099 GET /v1/drugs/5cdeaf00-6ddf-4194-8eb9-c4c0b6050099?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innöndunarduft, hart hylki",
"source": "lyfjastofnun",
"atc_raw": "R03AK14",
"marketed": false,
"strength": "125 míkróg/62,5 míkróg",
"ma_number": "EU/1/20/1439/001-004 & 013",
"substance": "Indacaterolum INN acetat,Mometasonum INN fúróat",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "43981"
}See everything about indacaterol und mometason.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.